Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects

Rheumatology

Volumn 40, Issue 4, 2001, Pages 438-446

  Schrijver, I A ^a   Melief, M J ^a   Markusse, H M ^b   Van Aelst, I ^c   Opdenakker, G ^c   Hazenberg, M P ^a   Laman, J D ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b Zuiderziekenhuis   (Netherlands)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Bacteria; Cytokines; Gut; Matrix metalloproteinases; Peptidoglycan; Rheumatoid arthritis; T cells

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN PRESENTING CELL; ANTISEPSIS; ARTHRITIS; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENVIRONMENT; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; JOINT; LYMPHOCYTE PROLIFERATION; MALE; MEDIATOR; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RODENT; SAMPLE; SPLEEN; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE; TISSUE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PEPTIDOGLYCAN; SPLEEN; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0035042969     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. The genetic contribution to the pathogenesis of rheumatoid arthritis
2. HLA-DR and the development of rheumatoid arthritis
3. Expression of activation antigens on T cells in rheumatoid arthritis patients
4. Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis
5. Expression of the activation antigen CD27 in rheumatoid arthritis
6. Cytokine-regulated proteases in autoimmune diseases
7. Expression of CD28, CTLA4. CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: Implications for immunotherapy
8. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis
9. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis
10. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells
11. Role of cytokines in rheumatoid arthritis
12. Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action
13. Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis
14. DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: Characterization of the cytokine cascade and cellular composition
15. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis
16. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis
17. Infectious agents as triggers of reactive arthritis
18. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis
19. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis
20. Detection of Chlamydia tranchomatis DNA in joints of reactive arthritis patients by polymerase chain reaction
21. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis
22. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis
23. Review article: Bone and joint diseases in inflammatory bowel disease
24. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history
25. Are intestinal bacteria involved in the etiology of rheumatoid arthritis? Review article
26. Intestinal flora bacteria and arthritis: Why the joint?
27. The involvement of the gut in the pathogenesis of inflammatory synovitis
28. Intestinal bacteria and rheumatic disease
29. Peptidoglycan types of bacterial cell walls and their taxonomic implications
30. Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora
31. Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells
32. Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats
33. Detection of muramic acid in a carbohydrate fraction of human spleen
34. Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells
35. Responses of synovial fluid and peripheral blood mononuclear cells to bacterial antigens and autologous antigen presenting cells
36. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
37. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
38. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease
39. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
40. Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres
41. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis
42. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis
43. Cytokine production in whole blood cell cultures of patients with rheumatoid arthritis
44. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus
45. Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood
46. Cytokine production by synovial T cells in rheumatoid arthritis
47. Elevated interleukin-10 levels in patients with rheumatoid arthritis
48. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis
49. Gelatinase B in chronic synovitis: Immunolocalization with a monoclonal antibody
50. Localization of matrix metalloprotinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implications for bone resorption
51. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators
52. TNF-alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages
53. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications
54. Muramic acid in peripheral blood leukocytes of healthy human subjects
55. Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis
56. Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients
57. Infection breaks T-cell tolerance
58. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8 + T cells to cause immunopathology
59. Lipopolysaccharide interferes with the induction of peripheral T cell death
60. Microbial products induce autoimmune disease by an IL-12-dependent pathway